Pre-market hot trades in US stocks: AsiaStrategy down 14.02% in pre-market; CCSC Tech down 11.97% in pre-market
AsiaStrategy pre-market down 14.02%; CCSC Tech pre-market down 11.97%; Global Health Solutions pre-market up 165.86%; Bluejay Diagnostics pre-market up 110.70%; Baosheng Group pre-market up 59.52%
Popular Pre-Market Trades in U.S. Stocks
Top Gainers in U.S. Pre-Market Trading
Bluejay Diagnostics is up 110.70% in pre-market trading. According to recent key news:
-
On October 9, Bluejay Diagnostics announced an expanded collaboration with Japan's SanyoSeiko to help commercialize its new Symphony rapid testing platform for sepsis management. This news propelled the company's stock price to double in pre-market trading to $4.72.
-
On October 9, despite the improvement in stock price, the lack of profitability and revenue generation remains an issue.
-
On October 9, Bluejay Diagnostics' Symphony platform is still awaiting approval from the U.S. FDA, aiming to provide test results for the IL-6 protein associated with sepsis inflammation in about 20 minutes. The medical diagnostics industry is focused on rapid testing technologies.
Bausch Group is up 59.52% in pre-market trading. Based on recent important news:
- On October 8, Bausch Group analyst Carsten Menke pointed out that gold purchases by emerging market central banks may continue for 3 to 5 years, driving up gold prices. This move aims to reduce reliance on the U.S. dollar and mitigate risks from U.S. sanctions. Bausch Group raised its gold price target, stimulating the stock price increase. Data source: Jin10 Data. Structural factors in the gold market are driving this
